SINERGI MULTI LESTARINDO (SMLE.JK)
IDR 113.0
(-4.17%)
IDR 113.0
(-4.17%)
| Breakdown | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|
| Revenue | 185.47 Billion | 144.22 Billion | 126.55 Billion | 92.65 Billion |
| Cost of Revenue | 139.88 Billion | 109.25 Billion | 96.28 Billion | 71.09 Billion |
| Gross Profit | 45.59 Billion | 34.96 Billion | 30.27 Billion | 21.56 Billion |
| Operating Expenses | 37.43 Billion | 23.49 Billion | 20.8 Billion | 13.19 Billion |
| Selling, General and Administrative Expenses | 36.62 Billion | 23.46 Billion | 20.07 Billion | 13.14 Billion |
| Research and Development Expenses | - | - | - | - |
| Other Expenses | -806.83 Million | -33 Million | -727.33 Million | -50.79 Million |
| Cost and Expenses | 177.31 Billion | 132.74 Billion | 117.08 Billion | 84.28 Billion |
| Operating Income | 8.16 Billion | 11.47 Billion | 9.46 Billion | 8.36 Billion |
| Interest Expense | 3.13 Billion | 2.61 Billion | 2.59 Billion | 2.83 Billion |
| Income Tax Expense | 1.24 Billion | 1.86 Billion | 1.8 Billion | 1.07 Billion |
| Earnings before Tax | 4.36 Billion | 7.82 Billion | 6.77 Billion | 4.67 Billion |
| Net Income | 3.12 Billion | 5.96 Billion | 4.97 Billion | 3.59 Billion |
| Earnings Per Share Basic | 1.68 | 3.20 | 2.67 | 1.93 |
| Earnings Per Share Diluted | 1.68 | 3.20 | 2.67 | 1.93 |
| Weighted Average Shares Outstanding | 1.86 Billion | 1.86 Billion | 1.86 Billion | 1.86 Billion |
| Weighted Average Shares Outstanding (Diluted) | 1.86 Billion | 1.86 Billion | 1.86 Billion | 1.86 Billion |
| Gross Margin | 0.25 | 0.24 | 0.24 | 0.23 |
| EBIT Margin | 0.05 | 0.09 | 0.09 | 0.11 |
| Profit Margin | 0.02 | 0.04 | 0.04 | 0.04 |
| EBITDA | 9.21 Billion | 13.07 Billion | 11.14 Billion | 9.28 Billion |
| Earnings Before Tax Margin | 0.04 | 0.08 | 0.07 | 0.09 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 55.36 Billion | 55.46 Billion | 58.09 Billion | 185.47 Billion | 47.41 Billion | 43.43 Billion |
| Cost of Revenue | 40 Billion | 42.11 Billion | 43.62 Billion | 139.88 Billion | 35.58 Billion | 32.85 Billion |
| Gross Profit | 15.35 Billion | 13.35 Billion | 14.47 Billion | 45.59 Billion | 11.82 Billion | 10.57 Billion |
| Operating Expenses | 9.8 Billion | 10.96 Billion | 11.81 Billion | 37.43 Billion | 11.42 Billion | 9.55 Billion |
| Selling, General and Administrative Expenses | 11.22 Billion | 10.96 Billion | 8.92 Billion | - | 11.35 Billion | 9.51 Billion |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | 1.42 Billion | - | -2.88 Billion | -806.83 Million | -69.6 Million | -36 Million |
| Cost and Expenses | 49.81 Billion | 53.07 Billion | 55.43 Billion | 177.31 Billion | 47.01 Billion | 42.41 Billion |
| Operating Income | 5.54 Billion | 2.39 Billion | 2.65 Billion | 8.16 Billion | 398.51 Million | 1.02 Billion |
| Interest Expense | 1.63 Billion | 634.1 Million | 586.4 Million | 3.13 Billion | 730.87 Million | 745.42 Million |
| Income Tax Expense | 916.47 Million | 90.14 Million | 630.77 Million | 1.24 Billion | 105.14 Million | 94.88 Million |
| Earnings before Tax | 4 Billion | 217.21 Million | 1.45 Billion | 4.36 Billion | -292.9 Million | 321.36 Million |
| Net Income | 3.09 Billion | 127.14 Million | 820.28 Million | 3.12 Billion | -398.05 Million | 226.47 Million |
| Earnings Per Share Basic | 1.33 | 0.05 | 0.25 | - | -0.21 | 0.12 |
| Earnings Per Share Diluted | 1.33 | 0.05 | 0.25 | - | -0.21 | 0.12 |
| Weighted Average Shares Outstanding | 2.32 Billion | 2.32 Billion | 3.29 Billion | 1.86 Billion | 1.86 Billion | 1.86 Billion |
| Weighted Average Shares Outstanding (Diluted) | 2.32 Billion | 2.32 Billion | 3.29 Billion | 1.86 Billion | 1.86 Billion | 1.86 Billion |
| Gross Margin | 0.28 | 0.24 | 0.25 | 0.25 | 0.25 | 0.24 |
| EBIT Margin | 0.11 | 0.05 | 0.05 | - | 0.02 | 0.03 |
| Profit Margin | 0.06 | 0.00 | 0.01 | 0.02 | -0.01 | 0.01 |
| EBITDA | 5.95 Billion | 2.79 Billion | 3.06 Billion | - | 849.16 Million | 1.46 Billion |
| Earnings Before Tax Margin | 0.10 | 0.04 | 0.05 | 0.04 | 0.01 | 0.02 |
9505
HLMAF
SBSP3
XTRX
ANHYT
AUGR